Cytomegalovirus infection after COVID-19 in a kidney transplant patient, a case report

IF 0.2 Q4 UROLOGY & NEPHROLOGY

Journal of Renal Injury Prevention Pub Date : 2023-01-22 DOI:10.34172/jrip.2023.32042

M. Alizadeh, A. Elsagh, Mana Mohamadi Afrakoti, Z. Khavari

引用次数: 0

Abstract

COVID-19, with its complications and co-infections is the most important pandemic, which has placed great strain on even the most developed health care systems, especially on the kidney transplant patients. We present a case of cytomegalovirus (CMV) reactivation after remission of COVID-19 in a kidney transplant patient, admitted to the emergency department. Fever, dyspnea, weakness and tachypnea are the most common symptoms of COVID-19, which can mislead physicians to make inappropriate decisions. We concluded that CMV can potentially increase the mortality risk of kidney transplant recipients (KTRs).

查看原文本刊更多论文

肾移植术后巨细胞病毒感染1例

新冠肺炎及其并发症和合并感染是最重要的流行病，它甚至给最发达的医疗保健系统带来了巨大压力，尤其是肾移植患者。我们报告了一例新冠肺炎缓解后巨细胞病毒（CMV）再激活的肾移植患者，该患者入住急诊室。发烧、呼吸困难、虚弱和呼吸急促是新冠肺炎最常见的症状，这可能会误导医生做出不适当的决定。我们得出结论，巨细胞病毒可能会增加肾移植受者（KTRs）的死亡风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Renal Injury Prevention UROLOGY & NEPHROLOGY-

CiteScore

1.60

自引率

0.00%

发文量

期刊介绍： The Journal of Renal Injury Prevention (JRIP) is a quarterly peer-reviewed international journal devoted to the promotion of early diagnosis and prevention of renal diseases. It publishes in March, June, September and December of each year. It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views and renal biopsy teaching point. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy. A further aim of this journal is to emphasize and strengthen the link between renal pathologists/nephropathologists and nephrologists. In addition, JRIP welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology. Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted.